ID NZM024 AC CVCL_D827 SY NZM24 DR BioSample; SAMN14558329 DR cancercelllines; CVCL_D827 DR Cosmic; 2007661 DR Wikidata; Q54931550 RX CelloPub=CLPUB00227; RX PubMed=23658559; RX PubMed=32567790; CC Doubling time: 39.4 hours (CelloPub=CLPUB00227). CC Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (PubMed=23658559; PubMed=32567790). CC Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=32567790). CC Omics: Deep exome analysis. DI NCIt; C3224; Melanoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) CA Cancer cell line DT Created: 22-10-12; Last updated: 19-12-24; Version: 15 // RX CelloPub=CLPUB00227; RA Daukste L.; RT "Mathematical modelling of cancer cell population dynamics."; RL Thesis PhD (2012); University of Canterbury; Christchurch; New Zealand. // RX PubMed=23658559; DOI=10.3389/fgene.2013.00066; PMCID=PMC3647113; RA Stones C.J., Kim J.E., Joseph W.R., Leung E.Y., Marshall E.S., RA Finlay G.J., Shelling A.N., Baguley B.C.; RT "Comparison of responses of human melanoma cell lines to MEK and BRAF RT inhibitors."; RL Front. Genet. 4:66.1-66.6(2013). // RX PubMed=32567790; DOI=10.1111/pcmr.12908; PMCID=PMC7818249; RA Tran K.B., Gimenez G., Tsai P., Kolekar S., Rodger E.J., RA Chatterjee A., Jabed A., Shih J.-H., Joseph W.R., Marshall E.S., RA Wang Q., Print C.G., Eccles M.R., Baguley B.C., Shepherd P.R.; RT "Genomic and signalling pathway characterization of the NZM panel of RT melanoma cell lines: a valuable model for studying the impact of RT genetic diversity in melanoma."; RL Pigment Cell Melanoma Res. 34:136-143(2021). //